A single-centre prospective observational study into development of microcirculatory alterations and response to therapy in adult critically ill patients

• Conditions: circulatory shock and tissue hypoperfusion; cardiovascular collapse and low blood flow to the tissues; 10019280; 10007593

• Registration Number: NL-OMON40618
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 168

Inclusion Criteria

In order to be eligible to participate in this study, a subject must be adult (> 18 yrs-old) and meet the description of the study groups stated in the section 4.2, page 13 in the protocol.

Exclusion Criteria

Moribund

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Standard Operating Procedure for measurement of Microcirculatory perfusion<br /><br>(cutaneous / mucosal / sublingual tissues): vessel density parameters,<br /><br>microvascular flow index, and flow heterogeneity.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>